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Chronic allergic itch is a common symptom affecting
millions of people and animals, but its pathogenesis
is not fully explained. Herein, we show that periostin,
abundantly expressed in the skin of patients with
atopic dermatitis (AD), induces itch in mice, dogs,
and monkeys. We identify the integrin aVb3
expressed on a subset of sensory neurons as the
periostin receptor. Using pharmacological and ge-
netic approaches, we inhibited the function of
neuronal integrin aVb3, which significantly reduces
periostin-induced itch in mice. Furthermore, we
show that the cytokine TSLP, the application of AD-
causing MC903 (calcipotriol), and house dust mites
all induce periostin secretion. Finally, we establish
that the JAK/STAT pathway is a key regulator of
periostin secretion in keratinocytes. Altogether, our
results identify a TSLP-periostin reciprocal activation
loop that links the skin to the spinal cord via periph-
eral sensory neurons, and we characterize the non-
canonical functional role of an integrin in itch.INTRODUCTION
Atopic dermatitis (AD)—also known as (atopic) eczema—is a
common chronic allergic skin disease of humans and dogs
with an estimated prevalence of up to 25% of children, a preva-
lence that depends on the patient’s age, ethnic background, and
geographical origin (Odhiambo et al., 2009). This condition often
persists in adults (Abuabara et al., 2018). AD has a high impact
on the health of patients because of an elevated risk of co-mor-
bidities, such as arthritis, asthma, and allergic rhinitis (Eckert
et al., 2017). Because AD is also associated with a high preva-
lence of anxiety, depression, and sleep disorders, there is an
ensuing reduced quality of life and work productivity (Eckert
et al., 2018). As a result, AD leads to substantial healthcare ex-This is an open access article under the CC BY-Npenses for both patients and society (Adamson, 2017; Eckert
et al., 2017).
In addition to the classic erythema and eczematous lesions
with a characteristic age-related distribution, AD is associated
with a chronic recurrent itch that is often moderate to severe
(Shahwan and Kimball, 2017; Weidinger and Novak, 2016). The
mechanism of atopic itch is complex, because it begins with
the cutaneous release of a myriad of pruritogenic mediators,
including histamine, neurotrophins, eicosanoids, proteases,
and cytokines (reviewed in Bautista et al., 2014; Mollanazar
et al., 2016; Storan et al., 2015; Voisin et al., 2017). Notable pru-
ritus-inducing or pruritus-sensitizing cytokines are those typical
of T helper type 2 (Th2) immune reactions, such as interleukin
(IL) 4 and IL-13 (Cevikbas et al., 2014; Dillon et al., 2004; Oetjen
et al., 2017) and thymic stromal lymphopoietin (TSLP) (Wilson
et al., 2013).
Pruritogenic mediators secreted in the skin will generally bind
to their respective receptors located on neurites of peripheral so-
matosensory neurons with a cell body located in the dorsal root
ganglia (DRG) (reviewed in Bautista et al., 2014; Han and Dong,
2014; Mollanazar et al., 2016). These pruritogens will activate
either G-protein-coupled receptors (GPCRs) (Nguyen et al.,
2017; Wilson et al., 2011; Han et al., 2006; Imamachi et al.,
2009) or IL (Cevikbas et al., 2014) or toll-like receptors (Liu and
Ji, 2014), as well as transient receptor potential (TRP) channels
on DRG sensory neurons to begin the transduction of the itch
signal to the central nervous system (Imamachi et al., 2009; Kit-
taka and Tominaga, 2017; Shim et al., 2007). Similarly, sensory
neurons appear to co-opt classic immune pathways to mediate
chronic itch, which depends on neuronal IL-4Ra and JAK1
signaling (Oetjen et al., 2017). The next step in itch propagation
is the release of neurotransmitters from the primary afferents in
the spinal cord. Several neurotransmitters have been character-
ized that either excite and/or inhibit itch neurotransmission
(Ma, 2014; Mishra and Hoon, 2013, 2015). Among them, the B
natriuretic peptide (BNP), also known as natriuretic polypeptide
B (NPPB), was identified and found to be expressed by the small
subset of neurons in the DRG, which is involved in chemical-
induced itch. Thus, NPPB-expressing DRG neurons are believedCell Reports 31, 107472, April 7, 2020 ª 2020 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
to be the (inflammatory) itch neurons in the DRG (Mishra and
Hoon, 2013). Recently, somatostatin (SST) was also shown to
be expressed in itch-transmitting DRG neurons, of which nearly
all also secrete NPPB (Huang et al., 2018). These findings have
significantly improved our understanding of the itch sensation
in mice and humans, but we are still far from being able to suc-
cessfully and completely treat this noxious sensation associated
with many cutaneous and neurologic diseases (Carstens, 2008;
Oaklander, 2011; Paus et al., 2006; Yosipovitch and Samuel,
2008).
Periostin is a fasciclin extracellular matrix (ECM) protein that
exerts its function after binding to cell-surface receptors of the
integrin family that include aVb3 and aVb5 (Izuhara et al., 2017).
After stimulation with various stimuli, including transforming
growth factor b (TGF-b) and the Th2 cytokines IL-4 and IL-13,
periostin is secreted by at least three types of cells, including fi-
broblasts, epithelial cells, and endothelial cells (Izuhara et al.,
2017; Masuoka et al., 2012). Because of its fibroblast-rich envi-
ronment, periostin is highly expressed in the skin, where its
strongest immunostaining is found at the dermoepidermal junc-
tion (Yamaguchi, 2014). Periostin appears to be critical to the
granulation and remodeling stages of cutaneous wound healing,
because it promotes the differentiation and migration of fibro-
blasts and the proliferation of keratinocytes (Yamaguchi, 2014).
Furthermore, periostin was found to be expressed in several dis-
ease states in which fibrosis is observed, for example, hypertro-
phic scars, bronchial asthma, pulmonary and systemic fibrosis,
and psoriasis (Yamaguchi, 2014). Periostin is also produced in
the skin of both humans (Kou et al., 2014) and dogs with sponta-
neous AD (Merryman-Simpson et al., 2008; Mineshige et al.,
2015). This fibrogenic cytokine is upregulated after epicutaneous
allergen challenges in mouse (Masuoka et al., 2012; Shiraishi
et al., 2012) and dog (Olivry et al., 2016) models of AD; in the
latter, it is transcribed late, after an epicutaneous allergen prov-
ocation (Olivry et al., 2016). In humans with AD, serum levels of
periostin not only correlate with disease activity but also appear
to reflect the chronicity of the disease, because its levels are
highest when skin lichenification (thickening) is present (Kou
et al., 2014). Because periostin induces the secretion of the
Th2 cytokine-promoting TSLP by keratinocytes (Shiraishi et al.,
2012), an amplification loop involving periostin (i.e., periostin
/ TSLP / Th2 cytokines / periostin) is a mechanism
suspected to lead to the dermal remodeling and epidermal hy-
perplasia typical of chronic AD (Masuoka et al., 2012; Shiraishi
et al., 2012; Takahashi et al., 2016).
Because of the likely role of periostin in the pathogenesis of
chronic skin lesions of AD, we wondered whether it might also
induce pruritus in this disease. Herein, we characterize the pru-
ritogenic potential of periostin when injected into the skin of three
mammalian species. We confirm, using molecular, pharmaco-
logical, cellular, and physiological assays, that periostin can
directly activate the sensory neurons via integrin aVb3, whose
removal or inhibition reduces the pruritogenic effect of its ligand.
Finally, we show that TSLP, MC903, and house dust mites
(HDMs) all induce the expression and secretion of periostin in
keratinocytes, thereby confirming the possibility of a TSLP-
induced periostin release by epidermal cells, whichmight induce
not only chronic inflammation but also itch.2 Cell Reports 31, 107472, April 7, 2020RESULTS
Periostin Induces Itch in Mice, Dogs, and Monkeys
Because periostin is produced in large amounts in the skin of pa-
tients suffering from pruritic dermatoses such as AD and psoriasis
(Merryman-Simpsonet al., 2008;Mineshige et al., 2018), we spec-
ulated its possible role as a pruritogen. Therefore, we first tested
whether intradermal (i.d.) injections of periostin triggered itch
behavior in mice. Surprisingly, a single injection of periostin in the
dorsal neck of mice induced robust scratching behavior within
15minofan intracutaneous injection (Figure1A).Becausesomato-
sensory neuronsare involved in itch, pain, and touch,we thenused
the cheek injection model that is known to permit the discrimina-
tion of pain and itch behaviors in mice (Kardon et al., 2014; Shi-
mada and LaMotte, 2008). Interestingly, periostin injections in
the cheek caused robust scratching behavior similar to that of his-
tamine, whereas it did not induce wiping when compared with
capsaicin, the archetypal pain inducer in mice (Figures S1A and
S1B). We then verified whether periostin induced pain behavior
by directly applying it into the cornea, because only nociceptive
compounds, such as capsaicin, induce a wiping behavior when
added to the eye of mice (Mishra and Hoon, 2010). We found no
eye-wiping response to the ocular application of periostin, while
capsaicin caused robust eye-wipe behavior in wild-type mice
compared with TRPV1 knockout mice (Figure S1C).
Many exogenous and endogenous molecules—for example,
histamine—have been shown to induce itch in mice, but except
for IL-31, most of them are not conserved pruritogens among an-
imal species or humans (Olivry and Ba¨umer, 2015). Recombinant
mouse periostin has an approximately 85% and 90% amino acid
homology with that of monkeys and dogs, respectively. To
assess whether periostin induced itch in these higher mamma-
lian species, we injected mouse recombinant periostin (25 mg/
100 mL i.d.) in dogs and subcutaneously (s.c.) in monkeys. Excit-
ingly, we found that periostin induced robust scratching within
15 min of injection, irrespective of the route (intracutaneous or
s.c.) and body site (neck or thigh) of administration; meanwhile,
injections of their control had no influence on itch manifestations
(Figures 1B and 1C). Altogether, these results show that periostin
acts as a strong pruritogen with a behavioral response that is
conserved among mice, dogs, and monkeys.
Because many mediators derived from several immune cell
types can activate sensory neurons to induce itch, we wondered
whether the periostin-induced pruritus occurred because of direct
(primary) or indirect (secondary) stimulationof sensoryneurons.To
determine whether the periostin-induced itch followed mast cell
activation, we challenged deoxyribonucleoprotein (DNP)-specific
immunoglobulin E (IgE)-sensitizedmast cells with increasing con-
centrations of the hapten DNP or periostin. As expected, DNP
induced the degranulation of mast cells sensitized with anti-DNP
IgE, but periostin did not (Figures S1D and S1E). Furthermore,
wedidnotobserveperiostin-dependent change incalcium release
whenmast cells were directly stimulated with periostin alone, and
there was no enhancement of the DNP-induced calcium re-
sponses after the addition of periostin to DNP-sensitized mast
cells (FigureS1F). Similarly, to exclude the possibility that the stim-
ulation of skin resident or infiltrating immune cells by periostin
could release mediators that would indirectly stimulate
Figure 1. Periostin Induces Robust Itch
Behavior Mediated via Somatosensory
Neurons
(A) Scratching bouts following an i.d. injection of
vehicle (20 mL PBS, black circle) or periostin (5 mg/
20 mL, gray circle) into the dorsal neck of wild-type
C57BL/6J mice. Mice scratching bouts were
recorded for 0–15 and 15–30min. Periostin induced
significant scratching bouts in 0–15 min compared
with 15–30 min. We observed no change in vehicle
responsebetween0–15and15–30min.n=7–8mice
per group.
(B) i.d. injection of periostin (25 mg/100 mL, gray cir-
cle) or vehicle (100mL PBS, black circle) in the dorsal
neck of dogs. Durations of pruritus manifestations
(DPMs)weremeasuredfirst for0–15minandsecond
for 15–30min. Periostin induced significant DPMs in
0–15 min compared with 15–30 min. We found no
change in vehicle response between 0–15 and
15–30 min. n = 8 dogs per group.
(C) s.c. injection of periostin (25 mg/100 mL, gray
circle) or vehicle (100 mL PBS, black circle) in the
thigh of monkeys. The number of scratches were
recorded for 0–15 and 15–30min. Periostin induced
significant scratching responses in 0–15 min
compared with 15–30 min. There was no change in
vehicle responsebetween0–15and15–30min. n=5
monkeys per group.
(D) Scratching bouts following i.d. injection of vehicle (20 mL PBS, black circle) or periostin (5 mg/20 mL, gray circle) in the dorsal neck of control andmast-cell-deficient
mice. There was no change in periostin-induced scratching behaviors between control and mast-cell-deficient mice. n = 5–6 mice per group.
(E)Scratchingbouts followinga i.d. injectionof vehicle (20mLPBS,blackcircle) orperiostin in thedorsal neckofcontrol andBandTcell-deficientmice (5mg/20mL,gray
circle). We observed no change in periostin-induced scratching behaviors between control and B and T cell-deficient mice. n = 6 mice per group.
(F) Scratching bouts following i.d. injection of vehicle (20 mL PBS, black circle) or periostin (5 mg/20 mL, gray circle) in the dorsal neck of control and B, T, and NK cell-
deficient mice. There was no change in periostin-induced scratching behaviors between control and mutant mice. n = 6 mice per group.
All data were presented as the mean ± SEM in mice, dogs, and monkeys. One-tailed Student’s t test was performed between two groups to determine significance
(*p ˂ 0.05, **p ˂ 0.01).somatosensory neurons and cause itch, we injected periostin into
the neck of mice deficient in mast cells (Kit W-sash) (Grimbaldes-
ton et al., 2005), B and T cells (Rag1/), and B, T, and NK cells
(non-obese diabetic/severe combined immunodeficiency [NOD/
SCID]) (Bosma et al., 1983; Mombaerts et al., 1992; Shultz et al.,
1995); we then compared the induced itch response with that of
control littermates. We detected similar scratching bouts in the
mast-cell-,BandTcell-,orB,T,andnatural killer (NK)cell-deficient
and control mice (Figures 1D–1F). Altogether, these data suggest
that periostin-evoked itch does not specifically require mast cells,
lymphocytes, or pruritogens released when these cells are acti-
vated. In contrast, our results lead to the hypothesis that periostin
might induce itch via the direct activation of somatosensory
neurons.
Integrin Receptors for Periostin Are Present in DRG
Somatosensory Neurons
Periostin has been shown to bind to the heterodimeric aVb3, aVb5,
and aIIbb3 integrins (Gillan et al., 2002; Li et al., 2010; Ruan et al.,
2009). Hence, we investigated the expression of aV, b3, b5, and
aIIb homomers in DRG sensory neurons. We found, using qRT-
PCR, that these integrin subunits are consistently expressed in
mice, dog, andmonkey DRGs (Figures 2A–2C). By using immuno-
histochemistry (IHC) inmice, we found that the aV and b5 subunits
are expressed in almost all DRGneurons (FigureS2),whereas onlya small subset of such neurons expressed the integrin b3 subunit,
alongwith the itch neurotransmitter SST (Figure 2D). Because only
a small percentage of DRG neurons can transmit itch, we focused
our subsequent studies on the aVb3 integrin.
We have shown that the DRG somatosensory neurons respon-
sible for itch transmission co-express both NPPB and SST
(Huang et al., 2018). To assess whether these itch-specific neu-
rons also expressed the periostin receptor of interest, we used
SST-cre::tdTomato mice that exclusively have the red Tomato
protein in SST- and NPPB-positive neurons. Therefore, we per-
formed IHC using an antibody against the b3 integrin homomer.
Our results confirmed the expression of b3 in SST/NPPB-ex-
pressing DRG neurons. Indeed, 93% of these SST-positive neu-
rons were positive for b3 (135 of 145 cells), whereas only 4% of
the b3-positive neurons were negative for SST (6 of 145 cells).
Similarly, only 3% of SST/NPPB-positive cells were b3 negative
(4 of 145 cells), as shown in Figure 2E. Altogether, these obser-
vations indicate that the integrin aVb3 is expressed in a subset
SST/NPPB-expressing DRG sensory neurons known to trans-
duce inflammatory itch (Usoskin et al., 2015).
Periostin Directly Activates Itch-Transmitting DRG
Somatosensory Neurons
Somatosensory neurons in the DRG express receptors for the
pruritogens that activate them (Han et al., 2006, 2013; ImamachiCell Reports 31, 107472, April 7, 2020 3
Figure 2. Periostin Integrin Receptor Sub-
units Are Expressed in DRG Sensory Neu-
rons
(A–C) qRT-PCR was used to quantify the expres-
sion of subunits of integrin receptors relative to
glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) in the DRG of 4mice (A), 3 dogs (B), and 5
non-human primates (C). A minimum of two tech-
nical replicates were performed for mice and dogs,
and three technical replicates were performed for
non-human primate.
(D) Co-expression of the integrin receptor b3
subunit (green) and SST-tdTomato (red) in DRG
neurons. Scale bar, 75 mm.
(E) Both SST-tdTomato and integrin b3 were
quantified for overlapping and non-overlapping
populations. n = 3 mice, with an average of 3
sections per mouse.
All data in (A)–(C) were presented as mean ± SEM.et al., 2009). To investigate whether periostin directly activates
DRG sensory neurons, this cytokine was applied to cultured
DRG sensory neurons loaded with the calcium chelating dye
Fura-2AM (fura 2-acetoxymethyl ester). We first measured the
response of DRG sensory neurons to several concentrations of
periostin. We found an equal number of cells responding to peri-
ostin at 8, 16, and 32 ng/mL (Figure S3). Hereafter, we used peri-
ostin at 16 ng/mL throughout our study to measure the calcium
influx in DRG neurons. Periostin led to the entry of calcium into
neurons that similarly responded to the TRPA1 agonist allyl iso-
thiocyanate (AITC) (mustard oil) and TRPV1 agonist capsaicin
(Figure 3A). In parallel, we observed an increase in amplitude in
response to periostin in neurons that also reacted to the
TRPV1-activating capsaicin, TRPA1-activatingmustard, and po-
tassium chloride (KCl; Figure 3B). Periostin-dependent changes
in intracellular calcium were observed in about 10% ± 2% of
DRG sensory neurons (Figure 3C).
Next, we wondered whether the periostin-associated activa-
tion of DRG neurons involved the influx of extracellular or intra-
cellular calcium. The removal of extracellular calcium silenced
this neuronal activation induced by periostin (Figure 3D). More-
over, the intracellular signaling proteins PLC and/or Gbg did
not appear involved in this calcium response, because the use
of their respective inhibitors did not diminish the neuronal activa-
tion by periostin (Figure 3E). Altogether, these results indicate
that extracellular calcium is involved in the periostin-induced
neuronal activation.
We then isolated and cultured mouse DRG neurons and sepa-
rated the itch-transmitting neurons that expressed SST (shown
with arrowheads in Figure 3F). Our pilot data had shownweak in-
ward currents at 1 mg/mL; therefore, we used 10 mg/mL in our4 Cell Reports 31, 107472, April 7, 2020subsequent experiment. Using patch
clamping, these SST-positive neurons
directly responded to periostin with an in-
ward current (Figure 3F), but SST-nega-
tive neurons had no response to periostin.
In summary, we showed herein the direct
activation of SST-expressing itch-trans-
mitting neurons by periostin and that thisinvolved the entry of extracellular calcium to cause an inward
current into the neurons that also expressed TRPV1.
Lastly, previous studies have shown that TSLP and IL-31
transduce itch signals via their respective receptors on sensory
neurons (Cevikbas et al., 2014; Wilson et al., 2013). To determine
the overlap of the neurons activated by these pruritogens and
periostin, we assessed the ratiometric calcium response of
DRG neurons to periostin, IL-31, and TSLP. We calculated the
percentage of overlapping cells by counting the neurons re-
sponding to both periostin and either TSLP or IL-31 with neurons
normalized to the periostin response. We found that 16% of
TSLP-responding neurons did so with periostin (35 cells with
TSLP/225 cells with periostin) and about 38% of IL-31-activated
neuron overlapped with those responding to periostin (85 cells
with IL-31/225 cells with periostin). Altogether, these results
suggest the existence of populations of neurons responding to
periostin that overlap partially with those activated by the allergic
pruritogenic cytokines TSLP and IL-31.
The Blocking of Integrin aVb3 on DRG Sensory Neurons
Inhibits the Calcium Influx and Periostin-Induced Itch
First, we examined the effect of the broad integrin receptor
antagonist cilengitide on DRG sensory neurons. Cilengitide is a
potent antagonist of both aVb3 and aVb5 with low IC50 (half
maximal inhibitory concentration) in the nanomolar range (3
and 37 nM, respectively) (Goodman et al., 2002). To examine
whether cilengitide inhibited periostin-induced calcium re-
sponses, neurons were perfused with a buffer containing
100 nM of this antagonist. The periostin-dependent calcium
response was significantly reduced during cilengitide perfusion
(Figure 4A), thereby demonstrating that integrins are involved
Figure 3. Periostin Directly Activates DRG Sensory Neurons
(A) DRG neurons were pre-incubated (30 min) with the calcium dye Fura-2AM (5 mM), and the calcium influx was measured by exciting cells with alternating 340/
380 nm wavelengths. Arrows indicate cells responding to periostin, AITC mustard (TRPA1 agonist), and capsaicin (TRPV1 agonist).
(B) Recording showing the amplitude of cytosolic Ca2+ increase for a single region of interest taken every 100 ms.
(C) Periostin-induced calcium response in DRG neurons treated with periostin (16 ng/mL), AITC mustard (100 mM), and capsaicin (1 mM). nR 6 mice.
(D) There were no neuronal calcium responses to periostin in the absence of extracellular calcium. n = 3 mice.
(E) Periostin-induced calcium response was not affected by either the Gbg blocker gallein (100 mM) or the phospholipase C inhibitor U73122 (1 mM). n = 2 mice.
(F) SST-positive small-diameter neurons (white arrowhead in the left panel) were patched, and the inward current was measured in response to periostin (10 mg/
mL). The SST-positive neuron produced an inward current to periostin, suggesting the presence of the aVb3 integrin receptor on SST-positive cells. In the right
panel, we showed the SST-negative neuron (blank arrowhead) did not respond to periostin (10 mg/mL). SST-positive neurons are a small subset of TRPV1-
expressing neurons. In 11 SST-positive neurons, the average current induced by periostin was 58.4 pA (column bar). Nine SST-negative neurons showed no
current amplitude in response to periostin. nR 4 mice. Scale bar, 20 mm.
A dot point in the calcium imaging scatterplot represents one coverslip. All data were presented as mean ± SEM, and the significance differences between two
groups were determined by unpaired Student’s t test (**p% 0.01).in such calcium influx. Importantly, the perfusion with cilengitide
did not reduce either AITC or capsaicin-induced calcium re-
sponses on DRG sensory neurons (Figure 4A). However, which
of the two cilengitide-inhibited integrins was specifically involved
in the periostin-induced calcium response in sensory neurons
was not determined by this experiment.
Next, we wanted to assess whether the periostin-induced itch
behavior in mice would also be affected by the dual integrin in-
hibitor cilengitide. We first injected cilengitide into mice and
confirmed that alone, it did not induce itch behavior. We then in-
jected cilengitide intravenously (i.v.) and intraperitoneally (i.p.)
10 min before periostin i.d. injection. Finally, we mixed periostin
and cilengitide together and injected it s.c. Altogether, the peri-
ostin-induced itch behavior was significantly reduced when peri-ostin was administered after or with cilengitide by all three routes
of injections (Figure 4B), and the strongest inhibitory effect of
cilengitide was seen after i.v. pre-injections of this antagonist.
Integrin b3, TRPV1, TRPA1 and NPPB Mediate the
Periostin-Induced Itch
The a-integrin subunit of the aVb3 heterodimer is expressed in
nearly all DRG neurons (Figure S2). Becausemost cells respond-
ing to periostin are activated by the TRPV1 agonist capsaicin, we
suspected that the integrin aVb3-expressing neurons are a sub-
set of those that have TRPV1. We thus generated a conditional
knockout of b3 subunits from a subset of TRPV1-expressing
neurons by crossing a b3-flox mouse with a mouse that
expresses the Cre recombinase in its TRPV1-lineage neuronsCell Reports 31, 107472, April 7, 2020 5
Figure 4. Pharmacological Blockage of In-
tegrin Receptors Inhibits Both Calcium
Influx and Periostin-Evoked Itch Behavior
(A) Cilengitide (100 nM), a non-specific blocker for
integrin receptors aVb3 and aVb5, inhibits the per-
iostin-induced calcium response, but it had no
effect on the mustard- or capsaicin-induced
response. n = 4–5 mice, and each data point rep-
resents one coverslip.
(B) Injections of periostin (5 mg/20 mL) following the
co-administration of cilengitide by different routes
(100 nM) in mice. n = 5–6 mice each group.
All data were presented as mean ± SEM, and the
significance differences between two groups were
determined by unpaired Student’s t test
(*p% 0.05, **p% 0.01).(Mishra et al., 2011). We confirmed by IHC that the b3 subunit
was knocked out from the TRPV1-cre::b3/ mutant mice (Fig-
ure 5A) with an almost 95% reduction in expression (Figure 5B).
Because our immunostaining revealed that the b3 integrin was
expressed in SST-positive itch neurons (Figure 2D), this integrin
was conditionally knocked out of TRPV1-expressing DRG neu-
rons (Mishra et al., 2011). We observed a significant reduction
in the calcium response to periostin in these neurons; however,
we did not find change in the calcium influx generated by capsa-
icin (Figure 5C) suggesting these mice have no developmental
defect in TRPV1-expressing neurons. We then i.d. injected
TRPV1-cre::b3/micewith periostin (Figure 5D), histamine (Fig-
ure 5E), and chloroquine (Figure 5F). TRPV1-cre::b3/mice had
no significant changes in histamine- and chloroquine-induced
scratching bouts when compared with their control littermates.
Conversely, TRPV1-cre::b3/ mice injected with periostin ex-
hibited a significant near-complete reduction in scratching
behavior when compared with their control littermates, confirm-
ing that the observed decrease in itch depended on b3. To
examine whether the integrin receptor b3 was also important
for the pain and touch sensations, we used standard behavioral
assays to measure acute pain in TRPV1-cre::b3/ and
compared the results with those of experiments done with con-
trol littermates. TRPV1-cre::b3/ mice showed no apparent
differences in responses to thermal stimuli (both hot and cold)
or mechanosensation, and they had normal motor function (Fig-
ures 5G–5J).
Because the neuronal calcium response induced by the hista-
mine and chloroquine pruritogens depends on TRP channels
after activation of their respective receptors, we examined the
role of both TRPA1 and TRPV1 channels in the periostin-induced
calcium response. We first showed that periostin-responsive
neurons overlapped with those responding to AITC (mustard
oil) and capsaicin (Figures 3A and 3B). We then demonstrated
that the periostin-dependent neuronal calcium response was
significantly decreased in TRPV1/ and TRPA1/ and that
the decrease was highest in TRPV1//TRPA1/ double-
knockout mice (Figure 6A). Altogether, these results confirm
that the neurons activated by periostin use TRPV1 and TRPA1
synergistically. Because both TRPV1 and TRPA1 ion channels
are involved in transducing itch behavior in vivo (Cevikbas
et al., 2014; Imamachi et al., 2009; Lagerstro¨m et al., 2010; Mis-
hra et al., 2011; Sheahan et al., 2018; Wilson et al., 2011, 2013),6 Cell Reports 31, 107472, April 7, 2020we examined whether the periostin-induced itch required either
one or both of these TRP channels and found that it was signif-
icantly diminished in TRPV1 (Figure 6B) and TRPA1 (Figure 6C)
single-knockout mice and TRPV1/TRPA1 double-knockout
mice (Figure 6D).
Finally, we examined whether the itch-transmitting neuropep-
tide NPPB, which is expressed in a small subset of TRPV1-ex-
pressing neurons, was also involved in periostin-induced itch.
As expected, we found a significant reduction in scratching
bouts in mice deficient in NPPB compared with control animals
(Figure 6E). Altogether, our results suggest the involvement of
both TRPV1 and TRPA1 ion channels downstream of activated
integrin aVb3, with TRPV1 neurons releasing NPPB as a neuro-
peptide to transmit the pruritogenic signal to spinal cord
interneurons.
Keratinocytes Release Periostin in Response to the
Cytokine TSLP
In diseases such as AD, keratinocytes contribute to the initial
inflammatory response through the release of many neuro-
stimulatory mediators that include the Th2 cytokine TSLP (Wil-
son et al., 2013). We first verified that mouse keratinocytes
have a functional TSLP receptor (TSLPR) and IL-7a receptor
(TSLPR/ILR7a) complex (Figure S4A) in response to TSLP
(2 ng/mL) and that they expressed TSLPR protein in both the
mouse keratinocyte cell line and in skin lysates (Figure S4B).
Then, we showed that TSLP-stimulated keratinocytes induced
the release of periostin in vitro (Figure 7A). This TSLP-induced
periostin release was blocked by the JAK2 inhibitor SD 1008
and the STAT3 inhibitor niclosamide, thereby implicating the
JAK/STAT pathway downstream of the TSLPR in the produc-
tion and release of periostin by keratinocytes in response to
TSLP (Figure 7B). We then found that TSLP induced both phos-
phorylated STAT3 (pSTAT3; Figure 7C) and its ensuing translo-
cation into the nucleus of mouse keratinocytes depicted by
non-visible DAPI (40,6-diamidino-2-phenylindole) nuclear stain-
ing because of pSTAT3 on cells treated with TSLP (Figure S4C,
ix and x) compared with vehicle control (Figure S4C, iv and v).
Surprisingly, even though STAT5 and STAT6 are involved in the
IL-31 atopic itch cytokine pathway (Hermanns, 2015; Park
et al., 2012), we did not detect change in either of these tran-
scription factors in response to TSLP keratinocyte stimulation
(Figure S4D). Finally, we examined whether TSLP induced the
Figure 5. The Periostin-Mediated Itch
Behavior Implicates the Integrin Receptor
aVb3 in TRPV1-Expressing Neurons
(A) IHC showed the elimination of b3 in TRPV1-
cre::b3/ mice compared with either TRPV1-cre
or b3fl/fl alone as control. Scale bar, 75 mm.
(B) Quantification of b3-immunopositive cells of
DRGs from the TRPV1-cre::b3/ mice demon-
strated a significant reduction compared with
control littermates (b3fl/fl). n = 3–4 mice, and an
average of 3 sections from each mice was quan-
tified.
(C) Periostin-mediated calcium response is
reduced in TRPV1-cre::b3/ mice, but there was
no change in the capsaicin-induced calcium influx.
n = 3–4 mice, and each data point represents one
coverslip.
(D) Itch behavior following the injection in the nape
of the neck of vehicle (PBS) or periostin in control
and mutant (TRPV1-cre::b3/) mice. Periostin-
induced itch was significantly reduced in mutant
mice compared with control littermates. n = 5–6
mice per group.
(E) Itch response to i.d. injection of histamine in
control littermates and mutant (TRPV1-
cre::b3/) mice remained normal. n = 6 mice
per group.
(F) Itch response to i.d. injection of chloroquine
in control and TRPV1-cre::b3/ mice remained
normal. n = 5 mice per group.
(G) Hargreaves assays between control and
mutant (TRPV1-cre::b3/) littermates. Both
control and mutant mice had a normal with-
drawal latency. n = 6–7 per group
(H) Dry-ice cold assays between control and
mutant (TRPV1-cre::b3/) littermates. Both
control and mutant mice showed normal
behavior responses. n = 6–7 per group
(I) Touch (von Frey) tests between control and
mutant (TRPV1-cre::b3/) littermates. Both
control and mutant mice demonstrated normal
behavior responses. n = 6–7 per group
(J) Rotarod test shows motor deficits between control and mutant (TRPV1-cre::b3/) littermates. Both control and mutant mice had normal behavior
responses. n = 5 per group.
All data were presented as mean ± SEM. One-way ANOVA Dunn’s test was performed for equal or more than three groups (**p < 0.001), and unpaired
Student’s t test was performed to determine significance (*p % 0.01).release of periostin in vivo. We established that the s.c. injec-
tion of TSLP into the neck of mice caused a significant increase
in local cutaneous levels of periostin, which was accompanied
by the production of pSTAT3 (Figures 7C–7E). Altogether, these
results confirmed the involvement of the JAK/STAT pathway in
TSLP-induced periostin production and release in vivo.
Periostin Is Involved in Chronic Allergic Itch
Mice treated with the vitamin D3 analog calcipotriol (MC903)
develop itch, skin lesions, and a rise in IgE levels resembling
those of humans with extrinsic AD (Moosbrugger-Martinz et al.,
2017). Importantly, these changes do not depend on mouse
gender or on genetic background. We used C57BL/6 mice and
topically applied MC903 once daily for 7 days. This application
led to chronic AD-like skin changes (Figure 7F) and elevated
skin levels of periostin (Figures 7G and 7H). The topical applica-tion of MC903 to both b3-alone (control) and TRPV1-cre::b3/
mutant mice had a day-dependent increase in skin thickness
compared with their control treated with vehicle (ethanol) (Fig-
ure 7I). In contrast, MC903 applied to the dorsal neck of control
mice induced significant scratching bouts that were attenuated
in TRPV1-cre::b3/ mutant mice (Figure 7J).
Finally, we sensitized NC/NgA mice to Dermatophagoides far-
inae HDMs and then repeatedly challenged them with this ubiq-
uitous and potent allergen. The topical application of HDMs on
mouse dorsal skin led to elevated skin levels of periostin
compared with those of mice treated with the vehicle (mineral
oil; Figure S5A). As expected, periostin skin levels were reduced
significantly after treatment with the glucocorticoid betametha-
sone dipropionate (Figure S5A). Similarly and in parallel, HDMs
induced robust scratching behavior compared with untreated
controls and betamethasone dipropionate reduced suchCell Reports 31, 107472, April 7, 2020 7
Figure 6. The Periostin-Mediated Calcium Influx Involves the DownstreamActivation of TRPChannels and Periostin-Evoked Itch Dependent
on TRP Channels and Neuropeptide NPPB
(A) Periostin-induced calcium response was inhibited in TRPV1, TRPA1, and double-knockout (KO) mice. The percentage of neurons that responded to periostin
was normalized with KCl (1 mM). n = 3–4 mice, and each data point represents one coverslip. A minimum of two technical replicates were performed.
(B) i.d. injection of periostin in the dorsal neck of control littermates and TRPV1 KOmice. A significant reduction in itch behavior was observed in TRPV1 KOmice
compared with control littermates. n = 5–7 mice per group.
(C) Significant reduction in itch behavior in TRPA1 KO mice compared with control littermates. n = 6 mice per group.
(D) Double-KO (TRPV1 + TRPA1) mice compared with control littermates showed reduced itch behavior. n = 6 mice per group.
(E) Significant reduction in itch behavior in NPPB KO mice compared with control littermates. n = 6–7 mice per group.
All data were presented as mean ± SEM, Significance was determined by unpaired Student’s t test (*p = 0.01, **p% 0.008).scratching (Figure S5B). Overall, our results suggest that perios-
tin is one of the endogenous cutaneous pruritogens involved in
the itch that develops in the MC903 and HDM chronic allergic
mouse models.
In summary of the results of the experiments reported earlier,
we logically propose a model of periostin-integrin
aVb3-TRPV1/TRPA1-NPPB activation that links the skin and
sensory neurons and could explain the itch behavior during the
chronic stages of allergic skin diseases in mice and perhaps
other species (Figure 7K).
DISCUSSION
Herein, we show that periostin induces itch behavior by binding
to the integrin aVb3 in a subset of itch-transmitting neurons that
also express SST. We provide evidence supporting our hypoth-
esis that periostin is an important pruritogen for chronic allergic
itch. First, we established that periostin induced itch behavior
in three species (mice, dogs, and monkeys), thereby suggesting
an evolutionarily conserved pathway. We then showed that in
mice, the periostin-induced itch behavior was independent of
mast cells, T cells, B cells, and NK cells. We demonstrated
that the integrin aVb3 was important in the generation of itch
via DRG sensory neurons, with signal propagation involving the
TRPV1 and TRPA1 channels and the neuropeptide NPPB.
Next, we confirmed that keratinocytes secreted periostin in
response to the cytokine TSLP via the JAK/STAT pathway. We
finally reported the release of periostin in the skin of two mouse
models of allergic skin disease and that this allergic itch
depended on the b3 integrin. Overall, we report that periostin-
induced activation of the aVb3 integrin in DRG sensory neurons,
and we propose the involvement of a TSLP-periostin reciprocal
amplification loop that links the skin to sensory neurons to cause
chronic allergic itch.8 Cell Reports 31, 107472, April 7, 2020The Periostin-Induced Itch Is Mediated through Sensory
Neurons
AD is often triggered by exposure to allergens that leads to
chronic, often severe, cutaneous inflammation and its associ-
ated itch. An array of mediators has been shown to be
involved in the various facets of cutaneous inflammation and
the allergic itch response (Cevikbas et al., 2014; Cianferoni
and Spergel, 2014; Indra, 2013; Liu et al., 2016; Masuoka
et al., 2012; Oetjen et al., 2017; Shang et al., 2016; Wilson
et al., 2013). The fasciclin periostin is one of these chronic in-
flammatory mediators, but its direct stimulation of sensory
neurons and its involvement in the induction of itch had not
been reported earlier. Periostin, generally classified as an
ECM protein, is produced by several cell types, including
epithelial cells and fibroblasts (Masuoka et al., 2012; Ros-
selli-Murai et al., 2013). It has been suggested that immune
cells and parenchymal stromal cells are activated by periostin
and participate in the genesis of AD skin lesions (Kim et al.,
2017; Masuoka et al., 2012; Uchida et al., 2012). Periostin is
highly expressed in the skin of human patients—and dogs—
with spontaneous AD (Arima et al., 2015; Izuhara et al.,
2014, 2017; Kou et al., 2014; Masuoka et al., 2012; Mineshige
et al., 2018; Murota et al., 2017; Yamaguchi, 2014). Our re-
sults using immunodeficient mice suggest that periostin
directly activates sensory neurons; however, the indirect acti-
vation of other cells types (e.g., keratinocytes, fibroblasts, and
dendritic cells) by periostin remains possible and needs to be
investigated using sophisticated genetic strategies in mice. In
humans, serum levels of periostin correlate with the severity
and chronicity of AD skin lesions (Kou et al., 2014). Herein,
we showed that periostin induced itch behaviors in mice,
dogs, and monkeys, which suggests a direct relevance of
this cytokine not only in the generation of skin lesions but
also in that of itch.
Figure 7. Keratinocytes Secrete Periostin in Response to TSLP Stimulus and the Activation of the JAK/STAT Pathway
(A) TSLP provoked the release of periostin from BALB/MK2 mouse keratinocytes. Equal numbers of cells (50,000 cells/well) were plated and treated with 1 and
10 ng/mL of TSLP, and supernatants were analyzed after 24 h by ELISA. n = 3 independent treatments at each concentration.
(B) Inhibitory effect of the JAK2 inhibitor SD 1008 and the STAT3 inhibitor niclosamide on TSLP-induced periostin production and release by mouse BALB/MK2
keratinocytes. Cells were pre-treated for 4 h with SD 1008 or niclosamide, and then stimulated with 10 ng/mL of TSLP and periostin release measured by ELISA
after 24 h. n = 3 independent treatments at each concentration.
(C) Representative immunoblots of periostin and pSTAT3 showed that both were upregulated in mouse skin in response to TSLP (10 ng/mL) compared with
vehicle (PBS) treatment. Samples were probed with antibodies against periostin, calnexin, pSTAT3, and total STAT3.
(D) Quantification of periostin normalized with calnexin. n = 3 mice
(E) Quantification of pSTAT3 normalized with total STAT3. n = 3 mice.
(F) Topical application of vehicle (ethanol, left mouse) and 4 nmol of vitamin D analog calcipotriol (MC903, right mouse) each day up to 7 days. MC903 induced
erythema and scaling compared with ethanol-treated mice. The picture was taken on day 7.
(G) Representative immunoblot of periostin and calnexin as a control were performed using skin lysates of vehicle- and MC903-treated mice on day 7. MC903
(4 nmol) and ethanol were applied onto the neck of C57BL/6 mice.
(H) Quantification of periostin normalized with calnexin led to a significant increase in periostin production in mice treated withMC903 compared with ethanol. n =
4 mice.
(I) Skin thickness was measured on each day. MC903 induced skin thickness compared with vehicle-treated mice, but no change was seen in skin thickness
between control (black) and TRPV1-cre::b3/ (gray) littermates. n = 4–5 mice.
(J) MC903-induced scratching bouts were day dependent and significantly increased at day 7 when compared with day 1. TRPV1-cre::b3/ (gray) littermates
showed a significant reduction in scratching bouts compared with control littermates (black). n = 9 mice.
(K) TSLP, MC903, and HDMs induce the release of periostin in the skin. The secreted periostin then binds to the integrin receptor aVb3 on DRG sensory neurons,
activates downstreamTRP channels (TRPV1 and TRPA1) to later release the neurotransmitters/neuropeptidesNPPB in the spinal cord, and activates one ormore
interneurons to eventually induce itch.
All data in (A)–(J) were presented as mean ± SEM. One-way and two-way ANOVA Dunn’s tests were performed as appropriate (*p % 0.05, **p % 0.01), and
Student’s t test was performed between two groups (*p% 0.05, **p% 0.01).
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Periostin Activates the Integrin aVb3 on Sensory
Neurons
Integrins are transmembrane receptors that mediate the adhe-
sion between adjacent cells and/or the ECM. Integrins have
diverse roles in several biological processes, including cell
migration, development, wound healing, cell differentiation,
and apoptosis (Ghatak et al., 2016; Lee and Juliano, 2004).
Each integrin exists as a heterodimer consisting of an a subunit
and a b subunit (Hynes, 2002). Many painful conditions have
been associated with alterations in the ECM. Furthermore, integ-
rins are present on sensory neurons that mediate inflammatory
and neuropathic pain (Dina et al., 2004). The fibronectin/integrin
pair participates in the upregulation of P2X4 expression after
nerve injury and its subsequent neuropathic pain (Tsuda et al.,
2008). The upregulation of the integrin b1 subunit in small- and
medium-diameter neurons contributes to substance P-mediated
pain after mechanical injury of the capsular ligament (Zhang
et al., 2017). The role of integrins in the propagation of itch and
how integrins activate neuronal excitability in the DRG sensory
neurons have not been reported.
Our study has provided insights into the sensory biology of itch
mediated via the integrin aVb3. Thus, we speculate on the role of
integrin aVb3-mediated neuronal excitability through TRP chan-
nels via two possible pathways. First, the binding of the ligand
periostin to the integrin leads to neuronal signal transduction
through the Src kinase, which phosphorylates the TRP channels
TRPV1 and TRPA1 and causes an influx of calcium that leads to
the enhanced excitability of the sensory neurons and itch induc-
tion. A second hypothesis is that integrin and TRP channels are in
physical contact with each other and that the activation of the in-
tegrin directly leads to TRP channel activation. Further research
will be important to understand the neuronal mechanisms that
lead to itch mediated through the interaction between integrin
aVb3 and TRP channels.
Surprisingly, we found that another receptor for periostin, the
integrin aVb5, was also expressed by almost all DRG neurons,
but its role in sensory processing is still unclear and deserves
further investigation. We believe this integrin was not relevant
in itch transduction, because it appears to be expressed on all
DRG neurons, whereas itch-transmitting sensory neurons are a
small fraction of these DRG neurons. It is conceivable that the in-
tegrin aVb5 could play a role in cell adhesion and signaling, while
aVb3 would be involved in the generation of neuronal excitability
via TRP channels. The exact role of these various integrin
subunits needs to be explored in the future using mice with
neuron-specific deletions of single subunits. Similarly, the integ-
rins aVb3 and aVb5 are expressed in keratinocytes, but the pres-
ence of functional TRPV1 and TRPA1 in these epithelial cells is
the subject of controversy. Although some studies support the
presence of the TRPV1 and TRPA1 ion channels in keratinocytes
(Ho and Lee, 2015), several other reports suggest their absence
from mouse keratinocytes (Chung et al., 2003, 2004; Zappia
et al., 2016). Further studies using keratinocyte-specific
integrin-deficient mice are essential to resolve the role of kerati-
nocytes in the periostin-associated itch in AD. Altogether, our
findings suggest the role of the integrin aVb3 in itch, which could
be used as a potential therapeutic target in the treatment of itch
associated with AD.10 Cell Reports 31, 107472, April 7, 2020The Integrin aVb3 Uses TRP Channels and the
Neuropeptide NPPB to Transmit Periostin-Induced Itch
Both TRPV1 and TRPA1 are generally required for the transmis-
sion of itch and pain stimuli to the CNS in rodents (Basbaum
et al., 2009; Bautista et al., 2013; Julius, 2013; Julius and Bas-
baum, 2001; Wilson et al., 2011). Studies have shown that the
pro-allergic cytokine TSLP induces itch via the activation of
TRPA1 (Wilson et al., 2013). Another Th2 cytokine involved in
the AD-associated itch, IL-31, leads to activation of both
TRPV1 and TRPA1 (Cevikbas et al., 2014). We herein demon-
strated that the ECM protein periostin, which is also relevant in
the pathogenesis of chronic AD, activates both TRPV1 and
TRPA1 downstream of its aVb3 receptor, as shown for IL-31.
Herein, we found an overlap between neurons responsive to
periostin and those responsive to the two other pruritogenic
cytokines: IL-31 and TSLP. Altogether, this potential overlap be-
tween the endogenous AD-relevant mediators suggests that
these three cytokines might act synergistically to lead to and
then perpetuate chronic allergic itch.
The neurotransmitter NPPB has been shown to be relevant for
the mechanism of IL-31-associated and chemical-induced itch
(Mishra and Hoon, 2013; Pitake et al., 2018). We showed herein
that the binding of periostin to the integrin aVb3 is mediated via a
TRPV1- and TRPA1-induced neuronal depolarization that results
in the release of NPPB. A recent report shows that TRPA1 is not
co-localized with NPPB-expressing neurons in the DRG (Nguyen
et al., 2017), which suggests the existence of a parallel release of
other neurotransmitters/neuropeptides in the DRG in response
to peripheral pruritogens. After release, NPPB binds to its recep-
tor NPRA on spinal cord interneurons, which in turn depolarizes
and releases gastrin-releasing peptide (GRP) to activate gastrin-
releasing peptide receptor (GRPR)-expressing interneurons
before sending an itch signal to the brain (Mishra and Hoon,
2013). Our behavioral results implicate NPPB in the periostin-
mediated itch. Although NPPB plays an important role in
signaling between the DRG and the spinal cord, such signaling
does not exclude the involvement of other potential neurotrans-
mitters linked to TRPA1 channels.
The Secretion of Periostin Is Regulated by the TSLP
Activation of the TSLPR/JAK/STAT Pathway in
Keratinocytes
Several molecular responses could lead to chronic itch. The first
point of contact between the skin and the external/internal stim-
uli is the epidermis, which is made up mostly of keratinocytes.
Pro-allergic stimuli activate keratinocytes to release the cytokine
TSLP, a cytokine known to be involved in allergic itch, AD,
asthma, and other inflammatory conditions (Cianferoni and
Spergel, 2014; Indra, 2013; Straumann et al., 2001; West et al.,
2012; Wilson et al., 2013). The released TSLP could then bind
back to keratinocytes via an autocrine/paracrine mechanism
involving the TSLPR to induce the secretion periostin via the
JAK/STAT3 pathway. Could a vicious circle involving the recip-
rocal activation of the pruritogenic cytokines TSLP and periostin
be one of the explanations for the chronic itch of AD? Previous
studies have shown that the archetypal Th2 cytokines IL-4 and
IL-13, which are uniquely important to the pathogenesis of AD,
stimulate dermal fibroblasts to produce periostin and that such
cytokines activate integrin-expressing keratinocytes to produce
TSLP (Izuhara et al., 2014; Masuoka et al., 2012). Herein, we
show that TSLP also activates TSLPR-expressing keratinocytes
to secrete periostin. Thus, we hypothesize that the cytokines
activate each other’s secretion by keratinocytes, likely causing
a reciprocal amplification loop that results in more of each cyto-
kine being produced over time. Importantly, a vicious circle of
amplification such as this might occur without the need for any
external factor, such as AD-inducing allergens. Both TSLP (Wil-
son et al., 2013) and periostin (our work) are now shown to
induce itch by directly stimulating DRG sensory neurons.
TSLP, MC903, and HDMs all lead to an increase in the secretion
of periostin that could, hypothetically, result in the paracrine
release of more TSLP, resulting in the continuous stimulation of
itch-sensing DRG neurons to induce an ever-worsening itch
(Figure 7K). This cutaneous-neuronal interaction could be one
of the pathways involved in the chronic and often severe allergic
itch that is typical of AD in humans and dogs. The existence of a
putative TSLP-periostin inflammation and itch-promoting recip-
rocal amplification loop unveils the opportunity for therapeutic
interventions attempting to block this vicious cycle. Because
the anti-TSLP monoclonal antibody tezepelumab proved to
have only modest effects in treating the skin lesions of itch of
human AD (Simpson et al., 2017), interventions targeting perios-
tin or its integrin receptormight be alternatives worth exploring to
treat atopic itch.STAR+METHODS
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pClamp10 software Axon Instruments NA
NIS-Elements AR 5.02.01 Nikon NA
Other
Calcium Imaging Scope Nikon TE200
Axopatch-700B amplifier Axon Instrument N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Eclipse Ti Nikon, Melville (NY) N/A
Dynamic Plantar Aesthesiometer Ugo Basile, Italy 37450
Rotarod Rotomex 5 Columbus Instruments N/A
Hargreave’s Apparatus Ugo Basile, Italy N/A
Cold Test Dry Ice assay Brenner et al., 2012
BioTek Neo2 multimode plate reader BioTek N/ARESOURCE AVAILABILITY
Lead contact
Further information and requests for resources and reagents should be directed to the lead contact, Santosh K. Mishra (skmishra@
ncsu.edu).
Materials availability
There are restrictions to the availability of mouse and cell line generated in this study, due to potential requirements for Materials
Transfer Agreement (MTA) with the host institution at which these reagents were generated.
Data and code availability
This study did not generate/analyze DNA or protein datasets.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Experiments using animals including mice and dogs (Maltese-beagle), followed the North Carolina State University laboratory animal
care protocols approved by an Institutional Animal Care and Use Committee (IACUC) and for non-human primates (NHP) as per NIH
guidelines. Mice were housed in small social groups (4 animals) in individually ventilated cages under 12-hour light/dark cycles and
fed ad libitum. We used 8-12-week old mice both male and females for most of the experiments both in cell cultures as well as in
awake animals. For patch clamp studies, cell culture was prepared from female mice. The C57BL/6N and all other genetically modi-
fied and knockout (KO) mice (Trpv1-cre; Sst-IRES-Cre; TRPV1 KO; TRPA1 KO; mast cells deficient c-kit mice; B & T cells deficient
RAGKOmice and controls; B, T, and NK cells KOmice NOD/SCID and its control NOD) were purchased from the Jackson laboratory
(Ellsworth, Maine). TRPV1, TRPA1, and double KOmice were bred in house. Trpv1-IRES-Cre animals were bred to a floxed b3 allele
(Morgan et al., 2010), allowing a conditional deletion of b3 in sensory neurons. Sst-IRES-Cre knock-in line was crossed to conditional
alleles, to enable the Cre-dependent expression of tdTomato (Ai9) (Madisen et al., 2010) from the R26 locus. Genotyping of offspring
from all breeding steps was performed with genomic DNA isolated from tail snips and allele-specific primer pairs.
METHOD DETAILS
Itch and pain behavioral measurements
All behavioral experiments were conducted during the light cycle at ambient temperature (23C). Behavioral assessment of scratch-
ing behavior was conducted as described previously (Mishra et al., 2011). Briefly, mice were injected intradermal into the nape of the
neck with periostin (R&D), histamine, and chloroquine (all Millipore-Sigma) as described (Shimada and LaMotte, 2008). Compounds
were diluted in PBS and the same was used as a vehicle. For inhibitor study, cilengitide was first injected intradermal (i.d.) to observe
any unwanted effect on itch behavior. In separate experiments, cilengitide was injected i.v. and i.p. 10 minutes prior to periostin in-
jection in the dorsal neck. Additionally, we combined cilengitide and periostin together (mix) and injected i.d. into the dorsal neck of
mouse. Scratching behavior was recorded for 30 minutes and data was presented in bouts per 30 minutes for mice. One bout was
defined as scratching behavior toward the injection site between lifting the hind leg from the ground and either putting it back on the
ground or guarding/licking the paw with the mouth. Injections of periostin, and capsaicin in the mouse cheek itch/pain model were
performed as described previously (Shimada and LaMotte, 2008). For eye wipes assay, we dropped periostin and capsaicin on
mouse cornea and counted wipes for 1-minute. Injection volume was always 20ml in mice. For dog’s study, we injected periostin
(25mg/25ml) in the dorsal neck (s.c.) and behavior was recorded and quantified for 30 minutes as duration of pruritus manifestation
(DPM), as described earlier (Paps et al., 2016). For NHP studies, periostin (25mg/100ml) was injected in the NHP thigh (s.c.) on the
lateral side of the upper part of the hind limb; the skin area over the vastus lateralis muscle. The lateral side of the upper part of
the hind limb was chosen as an injection site because this location is safe and easy to access when animal is in a chair. The number
of scratches is easily countable in NHP. When different raters separately scored a single tape, the ratings indicated high interraterCell Reports 31, 107472, April 7, 2020 e3
reliability (coefficient of correlation, r > 0.95). This method of itch readout in NHP has been used and accepted (Ko and Naughton,
2000). The behavior was recorded for 30 minutes duration and number of scratches quantified. In NHP, a scratch is defined as
one brief (< 1 s) episode of scraping contact of the forepaw or hind paw on the skin surface
For pain measurement, we conducted experiment as described previously (Mishra and Hoon, 2013; Pogorzala et al., 2013). Mice
were acclimatized to plexiglass chambers for 20 minutes and Hargreaves (hot), Dry ice assay (cold), von-Frey (mechanical), and
Rotarod (proprioception) were performed on control and mutant mice. Each mouse was recorded twice, and average of each mea-
surements were presented. Experimenters were blind to the genotype or treatment of the mice used in behavioral experiments.
Allergic model to quantify chronic itch and periostin
C57BL6mice (Jackson Labs) were applied daily with MC903 (4nmol) and vehicle (97% ethanol) after brief anesthesia. Skin thickness
was measured using cutimeter as described (Fukuyama et al., 2015). Scratching behavior was video-monitored for 30 min on Day 1
and Day 7. On Day 7 skin was collected from vehicle andMC903 treatedmice for theWestern Blot (WB) as described below. NC/Nga
mice (Charles River, Japan) were sensitized and challenged with house dust mite (HDM) allergen (Dermatophagoides farina, Greer,
Lenoir, NC, USA as described previously (Fukuyama et al., 2018). In short, for sensitization, 30 mL of HDM inmineral oil (10mg/ml) was
applied topically to the clipped back twice weekly supported by tape stripping until visible lesions had developed. After development
of visible lesions mice were treated daily either with vehicle cream or betamethasone dipropionate (0.1% in lipoderm, n = 8). Appli-
cation of betamethasone dipropionate was reduced to every other day on day 26 because of significant weight loss). Scratching
behavior was video monitored for 60 min period immediately after HDM on day 42. For periostin measurement, mice were sacrificed
for determination of periostin in skin on day 43. A portion of back skin tissue were snap-frozen in liquid nitrogen. Briefly, samples were
homogenized under liquid nitrogen, and the homogenates were taken in 200 mL RPMI 1640 medium containing 1 mmol/L Pefabloc.
The amount of periostin was determined using ELISA according to the manufacturer’s instruction.
DRG cell culture
DRGs were isolated from mice and dissociated in 1ml of media containing 2.5U/ml of dispase (Fisher) and 2.5mg/ml of collagenase
(Fisher). After dissociation, the cells were washed with complete media (DMEM (HiMedia) with 10%FBS (Atlanta Biologicals) and 1%
PenStrep (VWR)) and pelleted at 1000 rpm for 15minutes. Approximately 30ml of the cell suspensionwas plated on 18mm round glass
slides with a coating of laminin (Sigma Aldrich) and poly-L-lysine (Sigma Aldrich) and incubated for 1.5 hours. Afterward, 1ml of
complete media was added, and the cells were incubated overnight. All incubation steps were done at 37C with 5%CO2.
Mast cell release and degranulation
Mouse bone marrow-derived mast cells were cultured from femurs of C57BL/6J mice as described (Jensen et al., 2006). Degranu-
lation was assessed by measuring b-hexoseaminidase release as described (Cruse et al., 2013) using mast cells sensitized with
100ng/ml anti-DNP IgE (SPE7 clone) (Sigma Aldrich) for 16 hmrs, before the cells were challenged for 30 minutes with the indicated
stimulus.
Calcium imaging on mast cells
Changes in cytosolic Ca2+ were assayed using ratiometric Fura-2 AMmeasurements as described (Cruse et al., 2013). Fluorescence
was measured at two excitation wavelengths (340 and 380 nm) and an emission wavelength of 510 nm using a BioTek Neo2 multi-
mode plate reader. The ratio of fluorescence readings was calculated following subtraction of background fluorescence of cells not
loaded with Fura-2 AM.
Immunohistochemistry
DRGswere dissected frommice with various genotypes. Double and single IHCwere performed as previously described (Mishra and
Hoon, 2013). Images were collected on an Eclipse Ti (Nikon, Melville, NY) fluorescent microscope. Sections were selected randomly,
and counting was performed on each DRG section and presented as mean of 3-5 sections from each mouse.
Quantification of periostin from mouse cell line
The murine keratinocyte cell line (Balb/MK2) was used in this study to determine the periostin production induced by TSLP. Cells
were cultured in EMEMmedium according to the previously describedmethod (Fukuyama et al., 2018). Confluent cells were exposed
to TSLP at 1 or 10ng/ml in FBS-free medium for 24 hr. Inhibitory effect of the JAK2 inhibitor, SD 1008 and the STAT3 inhibitor, niclo-
samide, on TSLP-induced periostin production was also quantified using the murine Balb/MK2 keratinocyte cell line. Confluent cells
were pre-exposed for 4 hr to SD 1008 (10 mmol/l) or niclosamide (10 mmol/l), before being exposed to the TSLP at 10ng/ml for a further
24 hr. After TSLP exposure, periostin levels in cell supernatant were determined by ELISA according to the manufacturer’s
instructions.
Calcium imaging on mouse DRG neurons
Before imaging, cells were incubated in 350mL of complete media containing 5mM Fura-2 AM (Enzo) for 30 min at 37C with 5%CO2.
During imaging, the cells were perfused with a buffer containing the following: 135mM sodium chloride, 3.2mM potassium chloride,e4 Cell Reports 31, 107472, April 7, 2020
2.5mM magnesium chloride, 2.8mM calcium chloride, 667mM monobasic sodium phosphate, 14.2mM sodium bicarbonate, and
10.9mMD-glucose (all fromVWR) with a pH between 7.00 and 7.40. The buffer and the holding plate were kept at 37Cwhile imaging.
Imaging data was collected on a TE200 inverted microscope using NIS Elements software (Nikon). Cells were exposed to 340 and
380nmwavelengths for 100ms and the A340/A380 ratio was calculated. Traces were analyzed using Excel and responses greater than
10% of the baseline were counted. Each data point in the scatterplots represents one coverslip.
Whole-cell patch clamp recordings in DRG neurons
The mouse DRGs were removed aseptically from SOM-reporter mice (6-8 weeks) and incubated with collagenase (1.25mg/ml,
Roche)/dispase-II (2.4 units/ml, Roche) at 37C for 90 min, then digested with 0.25% trypsin for 8 min at 37C, followed by 0.25%
trypsin inhibitor. Cells weremechanically dissociatedwith a flame polished Pasteur pipette in the presence of 0.05%DNase I (Sigma).
DRG cells were plated on glass coverslips and grown in a neurobasal defined medium (with 2% B27 supplement, Invitrogen) with
5 mMAraC and 5% carbon dioxide at 36.5C. DRG neurons were grown for 24 hours before use. Whole-cell patch clamp recordings
were performed at room temperature using an Axopatch-700B amplifier (Axon Instruments) with a Digidata 1440B (Axon Instru-
ments). Only SST-positive neurons (< 20) were recorded. SST-negative neurons were also recorded as control. The patch pipettes
were pulled from borosilicate capillaries (World Precision Instruments, Inc.) using a P-97 Flaming/Brown micropipette puller (Sutter
Instrument Co.). The pipette resistance was 4-6 MU for whole-cell recording of periostin–induced inward currents, as previously re-
corded (Han et al., 2018). The internal pipette solution contains (in mM): 126 K-gluconate,10 NaCl, 1MgCl2, 10 EGTA, 10 HEPES and
2Na-ATP (adjusted to pH 7.4 with KOH, Osmolority295-300 mOsm), and extracellular solution contains (in mM): 140 NaCl, 5 KCl, 2
MgCl2, 2CaCl2, 10 HEPES, 10 glucose, adjusted to pH 7.4 with KOH.
Reverse Transcription-PCR
RNA was isolated from fresh-frozen lumbar DRG from mice, dogs and NHP using RNA easy kit (QIAGEN, USA) according to the
manufacturer protocol. To synthesize cDNA 200ng of RNAwas usedwith 2mL random hexamer primers (Invitrogen) and SmartScribe
Reverse Transcriptase (Clontech), as described previously (Mishra and Hoon, 2013). Taqman probes for all genes were purchased
from Invitrogen. All samples were run on an Applied Biosystems StepOnePlus Real Time PCR System using Taqman Gene Expres-
sionMaster Mix (Applied Biosystems, Cat # 4369016) with the recommended qPCR cycle. CT values were calculated using StepOne
Software v2.2.2 (Applied Biosystems). GAPDH was used as a housekeeping gene for normalization. Relative tissue expression
values were calculated using the following equation: relative expression = 2 –DCT.
Western blot (WB)
To extract total protein, dorsal root ganglia, and skin were homogenized using a tissue homogenizer in the presence of 100 mL of ice
cold RIPA buffer supplemented with protease inhibitor tablets (Pierce). Total protein of lysates was measured using standard BCA
(Bicinchoninic Acid Assay). Protein lysates were then denatured by heating at 95C in Laemmli’s buffer containing 2% w/v SDS,
62.5mM Tris (pH 6.8), 10% glycerol, 50mM DTT, and 0.01% w/v bromophenol blue. The lysates were cooled on ice and briefly mi-
cro-centrifuged. Aliquots of 35 mg of protein were loaded onto a 10% SDS-PAGE gel, and subsequently electro blotted onto PVDF
membranes. Membranes were incubated in 15ml of blocking buffer (20mM Tris base and 140mM NaCl, 5% bovine serum albumin,
and 0.1% Tween-20) for 1 hour. Membranes were then incubated with the desired primary antibody diluted in 10ml of blocking buffer
at 4C overnight. Next day membrane was washed and incubated with an appropriate horseradish peroxidase-conjugated second-
ary antibody (1:1000) to detect proteins in 10ml blocking buffer for 1-hr at room temperature. Immuno-reactive proteins were
revealed using enhanced chemiluminescence detection (Pierce ECL). The densitometry analysis was performed using open sourced
ImageJ software from NIH. Anti-TSLP receptor antibody was used at 1ng/ml. All other primary antibodies were used at a dilution of
1:1000. Secondary anti-rabbit and anti-mouse antibodies were purchased from Santa Cruz Biotechnology and used in 1:1000
dilution.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses and graphs were made in Prism 8 (GraphPad Software, La Jolla, CA). Differences between mean values were
analyzed using unpaired one-tailed and two-tailed Student’s t test as appropriate or 1-way/2-way analysis of variances (ANOVA)
with Dunn’s multiple comparisons post hoc test when more than two data groups were compared. Differences were considered
significant for *p < 0.05. p values definition, and number of replicates as well as definitions of center and dispersion were given in
the respective figure legend. No statistical method was employed to predetermine sample sizes. The sample sizes used in our
experiments were similar to those generally used in the field.Cell Reports 31, 107472, April 7, 2020 e5
